| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ADAMAS PHARMACEUTICALS INC | 100,000 | 1,514,000 | 0.62% | ||
| 52 | SAGE THERAPEUTICS INC | 50,000 | 1,507,000 | 0.61% | Call | |
| 53 | SERES THERAPEUTICS INC | 50,000 | 1,453,000 | 0.59% | ||
| 54 | CYTOKINETICS INC | 150,000 | 1,424,000 | 0.58% | ||
| 55 | APPLIED GENETIC TECHNOL CORP | 100,000 | 1,413,000 | 0.57% | ||
| 56 | ALNYLAM PHARMACEUTICALS INC | 25,000 | 1,387,000 | 0.56% | ||
| 57 | ALNYLAM PHARMACEUTICALS INC | 25,000 | 1,387,000 | 0.56% | Call | |
| 58 | REVANCE THERAPEUTICS INC COM | 100,000 | 1,360,000 | 0.55% | ||
| 59 | TANDEM DIABETES CARE INC COM | 175,000 | 1,320,000 | 0.54% | ||
| 60 | ALKERMES PLC | 30,000 | 1,297,000 | 0.53% | ||
| 61 | MINERVA NEUROSCIENCES INC COM | 125,000 | 1,276,000 | 0.52% | ||
| 62 | COHERUS BIOSCIENCES INC COM | 75,000 | 1,267,000 | 0.52% | ||
| 63 | WALGREENS BOOTS ALLIANCE INC | 15,000 | 1,249,000 | 0.51% | ||
| 64 | CLOVIS ONCOLOGY INC | 90,000 | 1,235,000 | 0.50% | ||
| 65 | MYLAN N V | 25,000 | 1,081,000 | 0.44% | ||
| 66 | INTRA-CELLULAR THERAPIES INC | 25,000 | 971,000 | 0.39% | ||
| 67 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 75,000 | 806,000 | 0.33% | ||
| 68 | ADMA BIOLOGICS, INC. | 125,000 | 744,000 | 0.30% | ||
| 69 | SERES THERAPEUTICS INC | 25,000 | 726,000 | 0.30% | Put | |
| 70 | SANGAMO THERAPEUTICS INCORPORATED | 125,000 | 724,000 | 0.29% | ||
| 71 | PACIFIC BIOSCIENCES CALIF IN | 100,000 | 704,000 | 0.29% | ||
| 72 | CHEMOCENTRYX INC | 150,000 | 674,000 | 0.27% | ||
| 73 | ENDOCHOICE HLDGS INC | 125,000 | 613,000 | 0.25% | ||
| 74 | MEDIVATION INC | 10,000 | 603,000 | 0.25% | ||
| 75 | CLEARSIDE BIOMEDICAL INC | 75,015 | 526,000 | 0.21% | ||
| 76 | IMMUNOMEDICS INCORPORATED | 225,000 | 522,000 | 0.21% | ||
| 77 | FLUIDIGM CORP DEL COM | 50,000 | 452,000 | 0.18% | ||
| 78 | EXELIXIS INC | 50,000 | 391,000 | 0.16% | Call | |
| 79 | NOVAVAX INC | 50,000 | 364,000 | 0.15% | Put | |
| 80 | RIGEL PHARMACEUTICAL INC | 150,000 | 335,000 | 0.14% | ||
| 81 | SCYNEXIS INC | 125,000 | 271,000 | 0.11% | ||
| 82 | RIGEL PHARMACEUTICALS INC | 50,000 | 112,000 | 0.05% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001597549-16-000021, filed 2016.11.04).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
